Intellia Therapeutics (NTLA) EBITDA Margin Growth (1y) (2016 - 2026)
Intellia Therapeutics (NTLA) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
3,695.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
3,695.00 |
| Dec 31, 2025 |
60,617.00 |
| Sep 30, 2025 |
70,793.00 |
| Jun 30, 2025 |
140,196.00 |
| Mar 31, 2025 |
-31,075.00 |
| Dec 31, 2024 |
-784,775.00 |
| Sep 30, 2024 |
-42,393.00 |
| Jun 30, 2024 |
-119,704.00 |
| Mar 31, 2024 |
40,599.00 |
| Dec 31, 2023 |
764,710.00 |
| Sep 30, 2023 |
-16,462.00 |
| Jun 30, 2023 |
-19,035.00 |
| Mar 31, 2023 |
57,343.00 |
| Dec 31, 2022 |
-17,036.00 |
| Sep 30, 2022 |
2.31 Mn |
| Jun 30, 2022 |
32,226.00 |
| Mar 31, 2022 |
-63,644.00 |
| Dec 31, 2021 |
-1,091.00 |
| Sep 30, 2021 |
-2.38 Mn |
| Jun 30, 2021 |
-84,997.00 |
